Vaginal Rejuvenation Market
Vaginal Rejuvenation Market Study by Reconstructive, Functional, and Cosmetic Treatment for Hospitals and Clinics From 2024 to 2034
Analysis of Vaginal Rejuvenation Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vaginal Rejuvenation Market Outlook (2024 to 2034)
The global vaginal rejuvenation market is evaluated to reach a valuation of US$ 3.97 billion in 2024 and further expand at a double-digit CAGR of 13.2% to end up at US$ 13.7 billion by 2034.
The market is driven by the growing acceptance of radiofrequency-based therapies. Due to their safe single-session results and non-invasive nature, radiofrequency-based devices, such as Viveve and Geneveve are becoming more popular.
While Genevieve's 30-minute treatment has improved the health and quality of life for thousands of women worldwide, Viveve provides volumetric radiofrequency of (90J/cm²) 3-5mm in vaginal tissue, which enhances blood circulation. In addition, the therapy is successful in treating vaginal elasticity loss and dryness brought on by delivery, as per the vaginal rejuvenation industry analysis.
Among the conditions that are common in the United States are fecal incontinence, overactive bladder syndrome, pelvic organ prolapse, and urinary incontinence. In the United States, one of the following conditions affects around 24% of women. Specifically, 3.9 percent of women have pelvic organ prolapse, 16% have urine incontinence, and 9% have fecal incontinence, as per the vaginal rejuvenation industry outlook.
In the upcoming years, the market for vaginal rejuvenation is also expected to be driven by the growing demand for energy-based therapies. For the targeted surgery, energy-based devices employ thermal or non-thermal energy for several vaginal tissue layers. This aids in neovascularization, toughens elastic fibers, promotes collagen regeneration, and restores vaginal lubrication.
As stated in the vaginal rejuvenation industry analysis, the market expansion for vaginal rejuvenation is positively impacted by the increasing effectiveness of radiofrequency and laser technologies in enhancing tissue characteristics, dermatology, and cosmetic medicine.
The use of these technologies for vaginal rejuvenation has greatly increased the range of biological tissue-related treatment indications. As a result, gadgets that integrate these technologies enable women to fully enjoy, regain, and enhance their femininity.
| Report Attribute | Detail |
|---|---|
| Vaginal Rejuvenation Market Size (2024E) | US$ 3.97 Billion |
| Forecasted Market Value (2034F) | US$ 13.7 Billion |
| Global Market Growth Rate (2024 to 2034) | 13.2% CAGR |
| East Asia Market Value (2024E) | US$ 665.8 Million |
| India Market Value (2034F) | US$ 1.48 Billion |
| Clinics Segment Growth Rate (2024 to 2034) | 13.7% CAGR |
| Canada Market Value (2034F) | US$ 676.4 Million |
| Key Companies Profiled | Alma Lasers; Lutronic; ThermiGen LLC; BTL Group of Companies; Venus Concept; Viveve; Hologic; Amirall; Fotona; Candela Corporation; Hironic |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Growth Drivers
Revolutionary developments in the cosmetic and beauty industry increase the desire for body enhancement in women. The increasing popularity of vaginal transformation is gaining attention worldwide, as mentioned in the vaginal rejuvenation industry outlook. Usually, it is recommended for women whose vagina has widened due to vaginal delivery or aging.
Women think that vaginal reconstruction will increase their self-confidence and comfort. Progressively, it has become a common option for women. The above-mentioned factors are boosting the demand for these procedures.
The currently available treatment options for vaginal rejuvenation are reconstructive, functional, and cosmetic. Reconstructive rejuvenation surgeries are aimed at correcting and repairing the anatomical structure of a vagina.
In these procedures, surgeons decrease the diameter of the vagina and correct the incontinence, pelvic organ prolapse, and congenitally malformed vagina. They also repair defects caused after vaginal delivery.
Functional rejuvenation mainly focuses on the enhancement of sexual sensations. This is done by increasing clitoral stimulation for better sexual pleasure and the amplification of the G-spot by injecting collagen to make it more sensitive and large.
Cosmetic vaginal rejuvenation procedures are aimed at altering the appearance of the vulva and vaginal opening. These procedures include labioplasty, in which the inner labia are reduced and the unwanted fat from the mons pubis & the upper part of the labia majora is removed. In addition, the revirginization procedure is carried out to repair the hymen, and cordectomy is performed to reduce the clitoral cover.
What are the Concerns Related to This Surgery?
Despite of the rising no of rejuvenation treatments, vaginal rejuvenation surgical procedures carry the risk of complications, such as scarring, infections, impaired blood supply, and the impairment of the nerve, which is resulting in painful sexual intercourse or decrease sexual sensation. Vaginal transformation is performed by gynecologists or plastic surgeons to reduce the vaginal average diameter, mainly for sexual reasons.
Some developing countries are unaware of these technologies and, in certain countries, body enhancement is considered taboo. Moreover, vaginal rejuvenation treatments are very costly. These factors are hampering the growth of this market.
Recently, there has been an increase in innovative and non-invasive procedures as opposed to traditional surgical techniques, which indicate that these techniques are the safest and most effective with few or no complications caused after surgery. However, the major concern is that there is poor scientific confirmation of the efficiency of rejuvenation procedures.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Segment Wise Insights
Based on types, the cosmetic vaginal treatment held a noteworthy vaginal rejuvenation market share accounting for 69.6% at present in 2024. Perineoplasty is a sub-segment that is largely performed surgery in this type.
G-spot amplification, hymenoplasty, and labioplasty are also other opted surgeries that are gaining at a noteworthy CAGR in the forecast period. The rising personal income is a key incentive behind women taking an interest in these surgeries for enhanced sexual pleasures.
Vaginoplasty is the most opted surgery in the USA to lose the vaginal canal after childbirth. Labiaplasty is another treatment popular due to its effective results in treating issues in genital areas.
The reconstructive vaginal treatment segment is anticipated to gain the fastest growth in upcoming years owing to the rising no of patients reporting progression. The need for vaginal sensation is driving demand for correcting and repairing the vaginal structure.
Based on the end-user industry, the hospital segment is dominant as there is the availability of needed infrastructure and skilled staff, which is a major driver for this segment. The other specialist clinics segment is anticipated to gain the fastest CAGR in the forecast period.
Regional Outlook
The global market is segmented into North America, Latin America, Europe, and Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America is expected to be a dominant market in the global vaginal rejuvenation market, followed by Europe, due to the growth of the cosmetic and beauty market.
Moreover, the rising popularity of vaginal reconstruction and the introduction of new innovative non-invasive procedures over traditional invasive surgeries is also boosting the market.
The American Society of Plastic Surgeons reported a 30% increase in the number of vaginal operation procedures in the United States. However, the vaginal reconstruction market in the Asia Pacific excluding Japan and the Middle East & Africa (MEA) is expected to grow at a steady growth rate as there is low awareness about vaginal rebuilding procedures and body enhancement is limited to the face and few other body parts. In addition, the cost of these procedures is high, which limits the growth of the vaginal rejuvenation market in these regions.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
The medical industry is highly competitive due to being high profit. The industry players are focused on increasing precision and results to increase market reach. The growing investments in research and development in cosmetic surgeries have been encouraging the market players to offer effective solutions to gain a competitive edge in the market.
The market is highly competitive and vendors are focused on the expansion of their services to generate dominance. The key industry players investing more in research and technologies to launch new forms of surgeries. As the market is expanding these players need the high cost of surgeries and maintenance of standards to ensure profit margins in the longer run.
Segmentation of the Vaginal Rejuvenation Market Research
-
By Treatment Type :
- Reconstructive
- Functional
- Cosmetic
-
By End User :
- Hospitals
- Clinics
- Others
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Treatment Type
- 6.2. End-User
- 7. Global Market Analysis and Forecast, By Treatment Type
- 7.1. Reconstructive
- 7.2. Functional
- 7.3. Cosmetic
- 8. Global Market Analysis and Forecast, By End-User
- 8.1. Hospitals
- 8.2. Clinics
- 8.3. Others
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. Asia Pacific
- 9.6. East Asia
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Treatment Type and End-User for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Almirall
- 19.2. Viveve Medical
- 19.3. Fotona
- 19.4. Hologic
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Bn Forecast by Region
Table 2: Global Market US$ Bn Forecast by Treatment Type
Table 3: Global Market US$ Bn Forecast by End-User
Table 4: North America Market US$ Bn Forecast by Country
Table 5: North America Market US$ Bn Forecast by Treatment Type
Table 6: North America Market US$ Bn Forecast by End-User
Table 7: Latin America Market US$ Bn Forecast by Country
Table 8: Latin America Market US$ Bn Forecast by Treatment Type
Table 9: Latin America Market US$ Bn Forecast by End-User
Table 10: Western Europe Market US$ Bn Forecast by Country
Table 11: Western Europe Market US$ Bn Forecast by Treatment Type
Table 12: Western Europe Market US$ Bn Forecast by End-User
Table 13: Eastern Europe Market US$ Bn Forecast by Country
Table 14: Eastern Europe Market US$ Bn Forecast by Treatment Type
Table 15: Eastern Europe Market US$ Bn Forecast by End-User
Table 16: Asia Pacific Market US$ Bn Forecast by Country
Table 17: Asia Pacific Market US$ Bn Forecast by Treatment Type
Table 18: Asia Pacific Market US$ Bn Forecast by End-User
Table 19: East Asia Market US$ Bn Forecast by Country
Table 20: East Asia Market US$ Bn Forecast by Treatment Type
Table 21: East Asia Market US$ Bn Forecast by End-User
Table 22: MEA Market US$ Bn Forecast by Country
Table 23: MEA Market US$ Bn Forecast by Treatment Type
Table 24: MEA Market US$ Bn Forecast by End-User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 16: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 17: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 18: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 19: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 20: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Treatment Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End-User
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are segments explained in this vaginal rejuvenation market report?
The vaginal rejuvenation market is segmented based on treatment type, end user, and region.
What is the present size of the vaginal rejuvenation market?
The current valuation of this market is US$ 3.97 billion in 2024.
What is anticipation for future market growth?
The market is evaluated to reach US$ 13.7 billion by the end of 2034.
What is the rate of growth expected from this industry in the forecast period?
The global market for vaginal rejuvenation is analyzed to register growth with a CAGR of 13.2% through 2034.
Who are the key players in this market?
Almirall, Viveve Medical, Fotona, and Hologic. are some of the leading market players.
Vaginal Rejuvenation Market